Lung Transplant; Complications Clinical Trial
Official title:
Live Music Therapy to Reduce Anxiety, Pain and Improve Sleep in Post-Operative Lung Transplant Patients: A Pilot Study
The purpose of this prospective pilot study is to determine if live music therapy reduces patients' perception of pain and anxiety, reduces benzodiazepine use and pain medication use, length of stay in the ICU, and length of stay in hospital, and improves sleep in post-lung transplant patients. The purpose and objectives of the study are the following: - To determine if music therapist delivered patient preferred live music and therapeutic intervention will reduce participant's perceived anxiety in post-lung transplant patients. - To determine if music therapist delivered patient preferred live music and therapeutic intervention will reduce participant's perceived pain in post-lung transplant patients. - To determine if music therapist delivered patient preferred live music and therapeutic intervention in post-lung transplant patients will reduce participant's use of benzodiazepine medication for anxiety. - To determine if music therapist delivered patient preferred live music and therapeutic intervention three times in post-lung transplant patients will reduce participant's use of pain medication. - To determine if music therapist delivered patient preferred live music and therapeutic intervention in post-lung transplant patients will reduce participant's total time of intubation, length of stay in ICU, and length of stay in the hospital. - To determine if music therapist delivered patient preferred live music and therapeutic intervention will improve the quality and length of sleep in post-lung transplant patients.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05526950 -
Cytokine Filtration in Lung Transplantation: A Swedish National Study (GLUSorb)
|
N/A | |
Recruiting |
NCT05916495 -
An Evaluation of Remote Care (Questionnaire+Hybrid) in Patients Who Are Post-lung Transplant
|
N/A | |
Enrolling by invitation |
NCT05950724 -
RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant
|
Early Phase 1 | |
Active, not recruiting |
NCT05505422 -
Routine Versus Selective Intraoperative ECMO in Lung Transplant
|
N/A | |
Recruiting |
NCT05081141 -
HHV8 and Solid Organ Transplantation
|
||
Enrolling by invitation |
NCT04522388 -
Examining the Effect of Nutritional Supplementation on Skeletal Muscle Mass in Patients Awaiting Lung Transplant
|
N/A | |
Completed |
NCT04165161 -
Performance Diagnosis of a Patent Foramen Ovale During Lung Transplantation Using Transesophageal Echocardiography
|
N/A | |
Recruiting |
NCT05050955 -
AlloSure Lung Assessment and Metagenomics Outcomes Study
|
||
Withdrawn |
NCT03258801 -
Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis
|
||
Completed |
NCT04892719 -
4DX Functional Lung Imaging in the Diagnosis of Chronic Lung Allograft Dysfunction After Lung Transplantation
|
N/A | |
Completed |
NCT03221764 -
Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients
|
Phase 2 | |
Completed |
NCT05116748 -
COVID19 Vaccine in SOT Adult Recipients
|
||
Recruiting |
NCT03367221 -
Physiological Response in Lung Transplant Recipients Undergoing Neurally Adjusted Ventilatory Assist
|
N/A | |
Recruiting |
NCT03276403 -
Primary Graft Dysfunction Score in Lung Transplantation
|
N/A | |
Active, not recruiting |
NCT03656926 -
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2)
|
Phase 3 | |
Completed |
NCT05242289 -
Cytokine Adsorption in Lung Transplantation
|
N/A | |
Recruiting |
NCT04837339 -
Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
|
N/A | |
Not yet recruiting |
NCT04377139 -
Management of Cytomegalovirus (CMV) Infection in Lung Transplant Recipients (LTR)
|
||
Not yet recruiting |
NCT06399302 -
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
|
||
Terminated |
NCT03562416 -
Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects
|
Phase 2 |